Evidence map›Paper›PMID 40235674›Full record

ArticleThe World Allergy Organization journal2025

Differential expression of eicosanoid pathways after whole blood stimulation in asthma patients.

Chrysanthi Skevaki, Pavel Tafo, Thomas Bahmer, Mustafa Abdo, Henrik Watz, Frauke Pedersen, Christian Herzmann, Klaus F Rabe, Harald Renz, Wolfgang Andreas Nockher and 1 more

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chrysanthi SkevakiInstitute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps-University Marburg, University of Giessen Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Marburg, Germany.
Pavel TafoInstitute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps-University Marburg, University of Giessen Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Marburg, Germany.
Thomas BahmerLungenClinic Grosshansdorf GmbH, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Mustafa AbdoLungenClinic Grosshansdorf GmbH, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Henrik WatzPulmonary Research Institute at LungenClinic Grosshansdorf GmbH, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Frauke PedersenLungenClinic Grosshansdorf GmbH, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Christian HerzmannForschungszentrum Borstel, Klinisches Studienzentrum, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.
Klaus F RabeLungenClinic Grosshansdorf GmbH, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Harald RenzInstitute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps-University Marburg, University of Giessen Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Marburg, Germany.
Wolfgang Andreas NockherInstitute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps-University Marburg, University of Giessen Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Marburg, Germany.
ALLIANCE Study Group as part of the German Center for Lung Research (DZL)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Asthma is a heterogeneous disease regarding its pathophysiology, clinical symptoms, and response to treatment. Eicosanoids are important inflammatory mediators, able to either promote or attenuate the underlying chronic airway inflammation. We compared eicosanoid expression patterns in the blood circulation and in stimulated blood leukocytes of asthma patients to identify differences in eicosanoid release which may be related to airway inflammation. Methods: Blood was collected from 198 adult asthmatic patients and 63 healthy controls, participating in the German Center for Lung Research (DZL) ALLIANCE cohort. Eicosanoid release from leukocytes was analyzed using heparinized whole blood after Results: Eicosanoid levels were low in blood circulation with no significant differences between asthmatics and controls, except for leukotriene E Conclusions: Profiling of eicosanoid production in stimulated whole blood samples showed a specific biosynthesis pattern of asthmatic patients, which is influenced by the use of systemic corticosteroids.

Indexed as

AsthmaEicosanoidsInflammation

Identifiers

PMID40235674
PMCPMC11999605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.